Safety and effectiveness of intravitreal dexamethasone implant in patients with ocular toxocariasis
British Journal of Ophthalmology · 2024
DOI: 10.1136/bjo-2022-322244 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Ophthalmology, 2024. Verfasst von Limei Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Zhongshan Ophthalmic Center State Key Laboratory of Ophthalmology, Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Nijmegen Breakage Syndrome, Toxocariasis, Macular Edema, Retinal Vein Occlusion. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Fundamental Research Funds of the State Key Laboratory of Ophthalmology, as well as research funds from Sun Yat-sen University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
To evaluate the safety and effectiveness of intravitreal dexamethasone (DEX) implant in patients with active uveitis due to ocular toxocariasis (OT).
Methods
Seventy-eight patients with OT were recruited in this retrospective study, including 51 patients in DEX group treated with intravitreal DEX implant and 27 patients in control group without intervention. The reduction of vitreous haze scores (VHS), the best-corrected visual acuity (BCVA) changes, intraocular pressure (IOP) and cataract progression and formation were recorded at baseline (V0), 1 (V1), 3 (V3) and 6 months (V6) after treatment in DEX group, and V0 and V6 in control group.
Results
There was no change in VHS and BCVA in control group between V0 and V6. Better VHS (p=0.001) and BCVA (p=0.022) was achieved in DEX group; the rate of VHS=0 was 0%, 67.4%, 42.9% and 44.9% at V0, V1, V3 and V6, respectively (p<0.001), and the mean BCVA was improved from logMAR 1.5±0.9 to 1.2±0.9 at V1, 1.4±1.0 at V3 and 1.4±1.2 at V6. A favourable BCVA at V1 was associated with older age (p=0.038) and uninvolved macula (p=0.000) in DEX group. No significant difference in IOP elevation ≥10 mm Hg, cataract progression and formation between groups. More eyes needed retinal surgery in control group (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhongshan Ophthalmic Center State Key Laboratory of Ophthalmology, Sun Yat-Sen University, Guangzhou, China.
- Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China.
- Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China dingxy75@gmail.com.
- Sun Yat-Sen University Zhongshan Ophthalmic Center State Key Laboratory of Ophthalmology, Guangzhou, China.
ORCID-Profile: Xiaoyan Ding
Förderung
- Fundamental Research Funds of the State Key Laboratory of Ophthalmology, as well as research funds from Sun Yat-sen University
- National Natural Science Foundation of China
Zitieren
APA
Sun, L., Huang, L., Li, S., Lu, J., Zheng, S., & Ding, X. (2024). Safety and effectiveness of intravitreal dexamethasone implant in patients with ocular toxocariasis. British Journal of Ophthalmology. https://doi.org/10.1136/bjo-2022-322244
Vancouver
Sun L, Huang L, Li S, Lu J, Zheng S, Ding X. Safety and effectiveness of intravitreal dexamethasone implant in patients with ocular toxocariasis. British Journal of Ophthalmology. 2024. doi:10.1136/bjo-2022-322244
BibTeX
@article{Sun2024,
author = {Sun, Limei and Huang, Li and Li, Songshan and Lu, Jinglin and Zheng, Shuxin and Ding, Xiaoyan},
title = {Safety and effectiveness of intravitreal dexamethasone implant in patients with ocular toxocariasis},
journal = {British Journal of Ophthalmology},
year = {2024},
doi = {10.1136/bjo-2022-322244}
}
EUVIMED